Project Score database: a resource that will help designing the next generation of anti-cancer drugs
A new paper published by Nuclear Acids Research and co-authored by Francesco Iorio, Group Leader at the Centre for Computational Biology, describes the creation of Project Score: a web portal enabling users to estimate the potential of each gene as a therapeutic target of future anti-cancer drugs.
Project Score, created and maintained by the group of Mathew Garnett at the Wellcome Sanger Institute, allows to browse data, download free datasets, and investigate specific biological hypotheses. For example, by specifying the name of any gene, the system will offer additional information on the gene’s target-priority score, potential biomarkers and tractability, including whether there are already drugs available to inhibit the corresponding coded protein.
The data underlying this resource has been made available thanks to CRISPR Cas9 whole-genome drop out screens which allow to better understand gene function and identify dependencies in cancer cells. The system is based on a computational pipeline developed by Francesco Iorio, Fiona Behan and Mathew Garnett and data described in a paper published last year in Nature, as part of the Cancer Dependency Map initiative.
Share:
You could also like:
-
Human Technopole Commitment to Gender Equality
Human Technopole is proud to announce the launch of its new Gender Equality Plan (GEP) for 2025-2027, a strategic initiative designed to further integrate gender equality across all aspects of the Institute, building upon the successful outcomes of the previous GEP (2022-2024). HT has also achieved the UNI/PdR 125:2022 certification, which recognizes organizations that promote gender equality and foster inclusive workplaces.
-
2 fully funded PhD fellowships at HT through SISSA
Human Technopole is offering 2 fully funded 4-year PhD fellowships to young scientists from the national and international community who wish to undertake a doctoral degree on a project focused on Computational Biology.
-
Advancing Precision Immunotherapy for Paediatric Leukaemia with Alice Giustacchini and her Group
Meet Alice Giustacchini, Research Group Leader in Population and Medical Genomics. Her project, titled “Tailoring Precision Immunotherapy to Paediatric Acute Myeloid Leukaemia,” aims to study the cellular and molecular dynamics of CAR-T cell therapy in blood cancers.
-
Human Technopole’s National Facilities: new Call for Access now Open
The new call for Access to the National Facilities services is now open! The Human Technopole’s National Facilities continue to expand their support for cutting-edge research by launching the first Call for Access of 2025. Building on the success of the 24-PILOT call, to which over 120 projects have applied, this new opportunity allows researchers to benefit from state-of-the-art technologies and expertise.
-
Childhood Cancer: Free DNA in Blood Reveals Therapy Resistance
An international study coordinated by Milan’s Human Technopole, the Institute of Cancer Research (ICR) in London, and the Royal Marsden Hospital in London has shown that certain DNA fragments found in the blood of paediatric cancer patients can be used as “biomarkers” to obtain information on the characteristics of the disease and its ability to resist therapies. Analysing these fragments could represent an effective alternative to tumour tissue biopsy, a practice that is particularly difficult in children.